Saturday, 31 October 2026European Markets

CLARANOVA Stock Bearish By 17% In The Last 5 Sessions

Loading stream...

(vianews) - shares of claranova (cac 40: cla.pa) fell by a staggering 17.99% in 5 sessions from €2.39 to €1.96 at 20:52 est on wednesday, after four sequential sessions in a row of losses. cac 40 is dropping 0.09% to €7,399.44, following the last session's downward trend.

claranova's last close was €1.97, 51.14% below its 52-week high of €4.03.

about claranova

claranova se, a technology company, engages in personalized e-commerce, software publishing, and internet of things businesses in the united states, the united kingdom, germany, france, other european countries, and internationally. it operates through three segments: planetart, avanquest, and mydevices. the planetart segment offers freeprints photobooks; freeprints photo tiles for wall decorations; freeprints cards; freeprints gifts and personal creations for personalized gifts; simplytoimpress; and cafepress and gifts.com websites. the avanquest segment provides the antivirus, ad blocker, cleaning, and optimization tools sold under the adaware brand; document management tools under the sodapdf brand name; and photo editor software and apps under the inpixio brand. the mydevices segment offers mydevices, an application platform that provides a range of iot solutions for the management of assets. it also provides signpdf, a new digital signature solution. the company was formerly known as avanquest s.a. and changed its name to claranova s.e. in june 2017. claranova se was incorporated in 1984 and is headquartered in la garenne-colombes, france.

earnings per share

as for profitability, claranova has a trailing twelve months eps of €-0.38.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -143.31%.

revenue growth

year-on-year quarterly revenue growth grew by 12.5%, now sitting on 508.5m for the twelve trailing months.

volume

today's last reported volume for claranova is 21285 which is 84.87% below its average volume of 117633.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, claranova's stock is considered to be overbought (>=80).

moving average

claranova's value is under its 50-day moving average of €1.99 and way below its 200-day moving average of €2.58.

more news about claranova (cla.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com